Visen Pharmaceuticals (Shanghai) Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Visen Pharmaceuticals (Shanghai) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia (NCT05246033) | Visen Pharmaceuticals (Shanghai) Co., Ltd. | 2022-01-05 |
| PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism (NCT05387070) | Visen Pharmaceuticals (Shanghai) Co., Ltd. | 2021-07-28 |
| Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency (NCT04326374) | Visen Pharmaceuticals (Shanghai) Co., Ltd. | 2019-12-30 |
Track Visen Pharmaceuticals (Shanghai) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.